RAC 3.77% $1.53 race oncology ltd

Ann: Race Initiates Heart Safety Preclinical Study for Bisantrene, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 164 Posts.
    lightbulb Created with Sketch. 591
    The relentless progress continues!

    Such exciting times to be initiating a trial focused directly on Bisantrene's FTO mechanism. I'm expecting the results of this study to be a huge catalyst.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.